Reply to the letter to the editor "Effects of vitamin D in patients with COVID-19 according to associated comorbidity"
Gac Med Mex
.
2022;158(5):339.
doi: 10.24875/GMM.M22000709.
Authors
Erick J Martínez-Rodríguez
1
,
Juan Gutiérrez-Mejía
1
,
Camilo Ríos-Castañeda
2
,
Sonia Rojas-Maya
3
,
Adrián Soto-Mota
1
Affiliations
1
Department of Hospital Reaction for Disasters, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán".
2
Neurochemistry Department, Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez".
3
Clinical Laboratory Department, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán". Mexico City, Mexico.
PMID:
36572027
DOI:
10.24875/GMM.M22000709
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Comorbidity
Humans
Vitamin D
Vitamin D Deficiency* / epidemiology
Vitamins / therapeutic use
Substances
Vitamin D
Vitamins